Go Back to Match Results for "trials"
Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) infection
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: COVID-19
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
Individuals at least 18 years of age diagnosed with COVID-19 and requiring invasive mechanical ventilation.
